Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ANTARES-PHARMA-INC-2956189/news/Lipocine-gibt-bekannt-dass-sein-Partner-Antares-Pharma-Inc-FDA-Akzeptanz-des-NDA-Wiedervorlagean-37746714/?utm_source=whatsapp&utm_medium=social&utm_campaign=share